SHORTTERM FOLLOW UP OF EVLA: COMPLICATIONS AND MANAGEMENTS, A SINGLE CENTER EXPERIENCE OF BANGLADESH


SHORTTERM FOLLOW UP OF EVLA: COMPLICATIONS AND MANAGEMENTS, A SINGLE CENTER EXPERIENCE OF BANGLADESH


Shantonu Kumar Ghosh, MS (CV&TS), Fellowship in vascular surgery1*, Md Mokhlesur Rahman, MS (CV&TS), Fellowship in vascular surgery1, Sultan Mahmud, MS (CV&TS)1, Md Mushfiqur Rahman, MS (CV&TS)1, Sarif Shammirul Alam, Diploma in Anesthesiology2, Alpana Majumder, Fellowship Trainee in Field Epidemiology3, Md Moynul Islam, Trainee in CVS1, SM Minhajul Hasan Chowdhury, MS (CV&TS)1, Md Shamim Reza, MS (CV&TS)1

1Department of Vascular Surgery, 2Department of Anesthesiology, National Institute of Cardiovascular Diseases, Sher-e-Bangla Nagar, Dhaka, Bangladesh. 3Institute of Epidemiology, Disease Control and Research, Mohakhali, Dhaka, Bangladesh.


Dodd and Cockett defined varicose veins, saying “a varicose vein is one which has permanently lost its valvular efficiency.” [1] Varicose veins constitute a progressive disease, remission of the disease does not occur, except after pregnancy and delivery. [2] The first documented reference of varicose veins was found as illustrations on Ebers Papyrus dated 1550 B.C. in Athens. [3]Greek philosopher Hippocrates (460-377 B.C.) described the use of compressive bandages and was advisor of small punctures in varicose veins. First patient who underwent operation for his varicose vein appears to be Canus Marius, the Roman tyrant. Giovanni Rima (1777-1843) introduced mid thigh ligation of the saphenous vein. Ligation of the sapheno-femoral junction as it is practiced today was first described by John Homans in his paper in 1916. [2] The Mayo Brothers, postulating that there would be additional benefit in removing the saphenous vein, pursued excision of the GSV through an incision extending from the groin to below the knee. The final technologic leap was introduction of the intraluminal stripper by Babcock. [2] In the era of minimally invasive surgery, the first documented case of Endovenous Laser Ablasion was published in 1999 using 810 nm Diode Laser. Since then several wavelengths were introduced; 810, 940, 980, 1064, 1320, 1470 and newly introduced 1940 nm. [4, 5]

It is generally agreed that varicose veins affect from 40 to 60% of women and 15 to 30% men. [6] During the 1930s to 1960s, several large studies reported the prevalence of varicose veins to roughly average 2% in the general population. [7] However, more recently, large population studies such as Edinburgh Vein Study demonstrated an age-adjusted prevalence of truncal varices of 40% in men and 32% in women. [8] Vein ablation is the most modern treatment option for superficial venous disease. Several endovenous modalities are getting popular for the treatment of varicose vein. Endovenous laser ablation therapy is the first endovenous procedure that had made the revolution in the treatment of varicose vein. [9] In Bangladesh, Laser ablation was first started at another center with 980 nm bare fiber and a good number of cases were done. We introduced ELVeSᴿ Radialᴿ fiber for the first time in the country using biolitecᴿ LEONARDOᴿ Mini 1470 nm during last week of March, 2018.


Keywords: EVLA; Complications and Managements; Bangladesh

Free Full-text PDF


How to cite this article:

Shantonu Kumar Ghosh, Md Mokhlesur Rahman, Sultan Mahmud, Md Mushfiqur Rahman, Sarif Shammirul Alam, Alpana Majumder, Md Moynul Islam, SM Minhajul Hasan Chowdhury, Md Shamim Reza. SHORTTERM FOLLOW UP OF EVLA: COMPLICATIONS AND MANAGEMENTS, A SINGLE CENTER EXPERIENCE OF BANGLADESH. American Journal of Surgical Research and Reviews, 2020; 3:10. DOI:10.28933/ajsrr-2020-11-2305


References

1. Borschberg E. The prevalence of varicose veins in the lower extremities. Thesis. Basel, Switzerland: S Karger, 1967.
2. Janugade HB, Patil BP, Tata NH, et al. Clinical profile and management of lower limb varicose veins. J Evolution Med Dent Sci. 2017; 6(20):1615-1622, DOI:10.14260/Jemds/2017/354
3. Iafrati MD, O’Donnell JR TF. Varicose veins: Surgical treatment. Rutherford 8th, pp 855-870.
4. Galanopoulos G, Lambidis C. Minimally invasive treatment of varicose veins: Endovenous laser ablation (EVLA). International Journal of Surgery. 2012; 10(3):134-139.
5. Park I. Initial outcomes of endovenous laser ab-lation with 1940 nm diode laser in the treatment of incompetent saphenous veins. Sagepub. 2018; 27(1): 27-32. Article first published online: September 7, 2018; Issue pub-lished: February 1, 2019. https://journals.sagepub.com/doi/abs/10.1177/1708538118797860.
6. Bergan JJ. Etiology and surgical management of varicose veins. Hobson/Wilson/Veith. Vascular surgery: principles and practice. Third edition, revised and expanded. Chapter- 67, pp. 949-962.
7. Van den Bos RR, de Maeseneer MMG. Endove-nous thermal ablation for varicose veins: strengths and weaknesses. Phlebolymphology. 2012;19(4):163-169.
8. Evans CJ, Fowkes FG, Ruckley CV, et al. Prev-alence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. Journal of Epidemiology and Community Health. 1999; 53 (3):149-153.
9. Ghosh SK. Trends on management of superficial venous disease. Int Surg J. 2020 Aug;7(8):2820-2823. DOI: http://dx.doi.org/10.18203/2349-2902. isj20203287
10. Joseph N, Abhishai B, Thouseef MF, et al. A multicenter review of epidemiology and man-agement of varicose veins for national guidance. Ann Med Surg (Lond). 2016 Jun; 8: 21–27. Pub-lished online 2016 Apr 30.
a. doi: 10.1016/j.amsu.2016.04.024
11. Agarwal V, Agarwal S, Singh A, et al. Prevalance and risk factors of varicose veins, skin trophic changes and venous symptoms among northern Indian population. Int J Res Med Sci. 2016 May;4(5):1678-1682.
12. Mousa A, El Azzazi M and Elkalla MA. Different management options for primary varicose veins in females: A prospective study. Surgery open sci-ence. Volume 1, Issue 1, July 2019. Pages 25-33.
13. Fowkes FGR. Epidemiology of venous ulcer. Phlébologie.1999; 52:377-382
14. Kavousi Y, Al Adas Z, Karamanos E, et al. Men present with higher clinical class of chronic ve-nous disease before endovenous catheter abla-tion. J Vasc Surg Venous Lymphat Disord. 2018Nov;6(6):702-706. doi: 10.1016/j.jvsv.2018. 05. 024.Epub 2018 Jul 29. PMID: 30064962.
15. Gough M, Gaunt M, Ikponmwosa A, et al. Post-procedure pain, safety and efficacy following great saphenous vein (GSV) endovenous laser ablasion (EVLA) using a 1470 nm diode laser. In Endovenous Laser Ablasion of varicose veins 10 years after: past, present and future. IUA World Congress, Buenos Aires – Argentina.April 21-25, 2010.
16. Nwaejike N, Srodon PD, Kyriakides C. Endove-nous laser ablation for the treatment of recurrent varicose vein disease- a single center experience. International Journal of Surgery. 8 (2010); 299-301.
17. Osman OA, El-Heeny AE, El-Razeq MA. Man-agement of primary uncomplicated varicose veins, endovenous laser ablation with sclero-therapy versus traditional surgery: which is the best option? Egypt J Surg 2019; 38:319-27.
18. Hung-Bun and Li-Fen Chao. Endovascular Abla-tion Therapies for Varicose Veins in Elderly Pa-tients. International Journal of Gerontology. 8 (2014); 219-222.
19. Theivacumar NS, Beale RJ, Mavor AID. Initial experience in endovenous laser ablation (EVLA) of varicose veins due to small saphenous vein reflux. Eur J Vasc Endovasc Surg. 33 (2007); 614-618.